Our pan-cancer analysis revealed that ALDOA is significantly upregulated across multiple cancer types, including lung squamous cell carcinoma, liver hepatocellular carcinoma, bladder cancer, and ovarian cancer. The gene discussed is ALDOA; the disease is urinary bladder carcinoma.